192 related articles for article (PubMed ID: 1479537)
1. Inhibition of hepatic mixed-function oxidase enzymes in mice by acute and chronic treatment with selenium.
Ishikawa M; Sasaki M; Koiwai K; Ozaki M; Takayanagi Y; Sasaki K
J Pharmacobiodyn; 1992 Aug; 15(8):377-85. PubMed ID: 1479537
[TBL] [Abstract][Full Text] [Related]
2. Effect of acute and repeated selenium treatment on hepatic monooxygenase enzyme activity in male rats.
Schnell RC; Early JL; Deimling MJ; Merrick BA; Davies MH
Toxicol Lett; 1983 Jun; 17(1-2):193-200. PubMed ID: 6414110
[TBL] [Abstract][Full Text] [Related]
3. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
[TBL] [Abstract][Full Text] [Related]
4. Changes in cytochrome P450 enzymes by 1,1-dichloroethylene in rat liver and kidney.
Hanioka N; Jinno H; Nishimura T; Ando M
Arch Toxicol; 1997; 72(1):9-16. PubMed ID: 9458185
[TBL] [Abstract][Full Text] [Related]
5. Changes in rat liver monooxygenase activities after administration of atenolol, nifedipine and diltiazem alone and in combination.
Kastelova A; Koleva M; Staneva-Stoytcheva D
Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):627-31. PubMed ID: 11256234
[TBL] [Abstract][Full Text] [Related]
6. Depression of the hepatic cytochrome P-450 monooxygenase system by treatment of mice with the antineoplastic agent 5-azacytidine.
Gooderham NJ; Mannering GJ
Cancer Res; 1985 Apr; 45(4):1569-72. PubMed ID: 2579731
[TBL] [Abstract][Full Text] [Related]
7. Effect of 2,4,4'-trichloro-2'-hydroxydiphenyl ether on cytochrome P450 enzymes in the rat liver.
Hanioka N; Jinno H; Nishimura T; Ando M
Chemosphere; 1997 Feb; 34(4):719-30. PubMed ID: 9569940
[TBL] [Abstract][Full Text] [Related]
8. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
Wade AE; Evans JL; Seitz A
Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
[TBL] [Abstract][Full Text] [Related]
9. Influence of chronic ethanol consumption on hamster liver microsomal O-dealkylase activities and cytochrome b5 content.
McCoy GD; DeMarco GJ; Biaglow JA
Biochem Pharmacol; 1985 Dec; 34(24):4263-7. PubMed ID: 4074385
[TBL] [Abstract][Full Text] [Related]
10. Biphasic effect of methadone on hepatic drug metabolism.
Komthong S; Yoovathaworn K; Thithapandha A
Proc Soc Exp Biol Med; 1987 Jan; 184(1):40-6. PubMed ID: 3797427
[TBL] [Abstract][Full Text] [Related]
11. Effects of horminone on liver mixed function mono-oxygenases and glutathione enzyme activities of Wistar rat.
Ferreira R; Candeias F; Simões F; Nascimento J; Cruz Morais J
J Ethnopharmacol; 1997 Sep; 58(1):21-30. PubMed ID: 9324001
[TBL] [Abstract][Full Text] [Related]
12. Postmortem changes in drug-metabolizing enzymes of rat liver microsome.
Yamazaki M; Wakasugi C
Forensic Sci Int; 1994 Aug; 67(3):155-68. PubMed ID: 7959472
[TBL] [Abstract][Full Text] [Related]
13. Ascorbic acid potentiates the substrate-specific inhibition of mixed-function oxidation and the stimulation of NADPH oxidation caused by paraquat.
Montgomery MR; Shamblin PB
J Toxicol Environ Health; 1984; 13(1):69-81. PubMed ID: 6716512
[TBL] [Abstract][Full Text] [Related]
14. Microsomal mixed-function oxidase and activities of some related enzymes in hyperplastic nodules induced by long-term griseofulvin administration in mouse liver.
Denk H; Abdelfattah-Gad M; Eckerstorfer R; Talcott RE
Cancer Res; 1980 Jul; 40(7):2568-73. PubMed ID: 7388813
[TBL] [Abstract][Full Text] [Related]
15. Influence of norethindrone on drug-metabolizing enzymes of female rat liver in various B-vitamin deficiency states.
Wade AE; Evans JS
Pharmacology; 1977; 15(4):289-301. PubMed ID: 408827
[TBL] [Abstract][Full Text] [Related]
16. Comparative incidence of oral ochratoxicosis and aflatoxicosis on the activity of drug-metabolizing enzymes in rat liver.
Galtier P; Larrieu G; Le Bars J
Toxicol Lett; 1984 Dec; 23(3):341-7. PubMed ID: 6441316
[TBL] [Abstract][Full Text] [Related]
17. Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation.
Meier PJ; Mueller HK; Dick B; Meyer UA
Gastroenterology; 1983 Sep; 85(3):682-92. PubMed ID: 6603386
[TBL] [Abstract][Full Text] [Related]
18. Role of neonatal androgen in the development of hepatic microsomal drug-metabolizing enzymes.
Chung LW; Raymond G; Fox S
J Pharmacol Exp Ther; 1975 May; 193(2):621-30. PubMed ID: 1142108
[TBL] [Abstract][Full Text] [Related]
19. Effects of methylbenzenes on microsomal enzymes in rat liver, kidney and lung.
Pyykkö K
Biochim Biophys Acta; 1980 Nov; 633(1):1-9. PubMed ID: 6778508
[TBL] [Abstract][Full Text] [Related]
20. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
